Literature DB >> 36040582

Updates on Cardiac Gene Therapy Research and Methods: Overview of Cardiac Gene Therapy.

Francisco J Romeo1, Spyros A Marvopoulos1, Kiyotake Ishikawa2.   

Abstract

Gene therapy has made a significant progress in clinical translation over the past few years with several gene therapy products currently approved or anticipating approval for clinical use. Cardiac gene therapy lags behind that of other areas of diseases, with no application of cardiac gene therapy yet approved for clinical use. However, several clinical trials for gene therapy targeting the heart are underway, and innovative research studies are being conducted to close the gap. The second edition of Cardiac Gene Therapy in Methods in Molecular Biology provides protocols for cutting-edge methodologies used in these studies. In this chapter, we discuss recent updates on cardiac gene therapy studies and provide an overview of the chapters in the book.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adeno-associated virus; Animal model; Assay; Delivery; Experiments; Promoter; Specificity; Targeting; Vector

Mesh:

Year:  2022        PMID: 36040582     DOI: 10.1007/978-1-0716-2707-5_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  29 in total

1.  CRISPR/Cas9 Gene editing of RyR2 in human stem cell-derived cardiomyocytes provides a novel approach in investigating dysfunctional Ca2+ signaling.

Authors:  Hua Wei; Xiao-Hua Zhang; Cassandra Clift; Naohiro Yamaguchi; Martin Morad
Journal:  Cell Calcium       Date:  2018-04-27       Impact factor: 6.817

2.  Pharmaceutical grade large-scale plasmid DNA manufacturing process.

Authors:  Marco Schmeer; Martin Schleef
Journal:  Methods Mol Biol       Date:  2014

3.  miR-25 Tough Decoy Enhances Cardiac Function in Heart Failure.

Authors:  Dongtak Jeong; Jimeen Yoo; Philyoung Lee; Sacha V Kepreotis; Ahyoung Lee; Christine Wahlquist; Brian D Brown; Changwon Kho; Mark Mercola; Roger J Hajjar
Journal:  Mol Ther       Date:  2017-11-26       Impact factor: 11.454

4.  CRISPR-Mediated Activation of Endogenous Gene Expression in the Postnatal Heart.

Authors:  Eric Schoger; Kelli J Carroll; Lavanya M Iyer; John McAnally; Wei Tan; Ning Liu; Claudia Noack; Orr Shomroni; Gabriela Salinas; Julia Gross; Nicole Herzog; Shirin Doroudgar; Rhonda Bassel-Duby; Wolfram Hubertus Zimmermann; Laura C Zelarayan
Journal:  Circ Res       Date:  2019-11-15       Impact factor: 17.367

5.  Pkm2 Regulates Cardiomyocyte Cell Cycle and Promotes Cardiac Regeneration.

Authors:  Ajit Magadum; Neha Singh; Ann Anu Kurian; Irsa Munir; Talha Mehmood; Kemar Brown; Mohammad Tofael Kabir Sharkar; Elena Chepurko; Yassine Sassi; Jae Gyun Oh; Philyoung Lee; Celio X C Santos; Avital Gaziel-Sovran; Guoan Zhang; Chen-Leng Cai; Changwon Kho; Manuel Mayr; Ajay M Shah; Roger J Hajjar; Lior Zangi
Journal:  Circulation       Date:  2020-02-11       Impact factor: 29.690

6.  miR-199-sponge transgenic mice develop physiological cardiac hypertrophy.

Authors:  Zhenhua Li; Lantao Liu; Ning Hou; Yao Song; Xiangbo An; Youyi Zhang; Xiao Yang; Jian Wang
Journal:  Cardiovasc Res       Date:  2016-03-14       Impact factor: 10.787

7.  Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy.

Authors:  A Moretti; L Fonteyne; F Giesert; P Hoppmann; A B Meier; T Bozoglu; A Baehr; C M Schneider; D Sinnecker; K Klett; T Fröhlich; F Abdel Rahman; T Haufe; S Sun; V Jurisch; B Kessler; R Hinkel; R Dirschinger; E Martens; C Jilek; A Graf; S Krebs; G Santamaria; M Kurome; V Zakhartchenko; B Campbell; K Voelse; A Wolf; T Ziegler; S Reichert; S Lee; F Flenkenthaler; T Dorn; I Jeremias; H Blum; A Dendorfer; A Schnieke; S Krause; M C Walter; N Klymiuk; K L Laugwitz; E Wolf; W Wurst; C Kupatt
Journal:  Nat Med       Date:  2020-01-27       Impact factor: 53.440

8.  AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction.

Authors:  Rabea Hinkel; Sandor Batkai; Andrea Bähr; Tarik Bozoglu; Sarah Straub; Tobias Borchert; Janika Viereck; Andrea Howe; Nadja Hornaschewitz; Lisa Oberberger; Victoria Jurisch; Rainer Kozlik-Feldmann; Franz Freudenthal; Tilman Ziegler; Christian Weber; Markus Sperandio; Stefan Engelhardt; Karl Ludwig Laugwitz; Alessandra Moretti; Nik Klymiuk; Thomas Thum; Christian Kupatt
Journal:  J Am Coll Cardiol       Date:  2021-06-15       Impact factor: 24.094

9.  Direct reprogramming induces vascular regeneration post muscle ischemic injury.

Authors:  Keerat Kaur; Yoav Hadas; Ann Anu Kurian; Magdalena M Żak; Jimeen Yoo; Asharee Mahmood; Hanna Girard; Rinat Komargodski; Toshiro Io; Maria Paola Santini; Nishat Sultana; Mohammad Tofael Kabir Sharkar; Ajit Magadum; Anthony Fargnoli; Seonghun Yoon; Elena Chepurko; Vadim Chepurko; Efrat Eliyahu; Dalila Pinto; Djamel Lebeche; Jason C Kovacic; Roger J Hajjar; Shahin Rafii; Lior Zangi
Journal:  Mol Ther       Date:  2021-07-29       Impact factor: 12.910

10.  miR-146a Suppresses SUMO1 Expression and Induces Cardiac Dysfunction in Maladaptive Hypertrophy.

Authors:  Jae Gyun Oh; Shin Watanabe; Ahyoung Lee; Przemek A Gorski; Philyoung Lee; Dongtak Jeong; Lifan Liang; Yaxuan Liang; Alessia Baccarini; Susmita Sahoo; Brian D Brown; Roger J Hajjar; Changwon Kho
Journal:  Circ Res       Date:  2018-08-31       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.